Sarcomas: Clinical Trials

2 trials for Sarcomas, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Sarcomas: new trials by email Literature Review of Sarcomas trials Research Report on Sarcomas

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Entrectinib - Breast Cancer, Cholangiocarcinoma
Phase 2CompletedHoffmann-La Roche5342015-11-192026-11-17
Dendritic Cell Vaccination for Patients with Solid Tumors
autologous dendritic cell vaccination - Glioblastoma, Renal Cell Carcinoma
Phase 1 / Phase 2CompletedUniversity Hospital, Antwerp482010-05-032024-12-09

Narrower conditions

Breast Neoplasms (2)  ·  Carcinoma, Renal Cell (2)  ·  Colorectal Neoplasms (2)  ·  Sarcoma (2)  ·  Brain Neoplasms (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cholangiocarcinoma (1)  ·  Glioblastoma (1)  ·  Head and Neck Neoplasms (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Melanoma (1)  ·  Mesothelioma, Malignant (1)  ·  Neuroendocrine Tumors (1)  ·  Ovarian Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Adenocarcinoma (2)  ·  Breast Diseases (2)  ·  Carcinoma (2)  ·  Colonic Diseases (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Intestinal Diseases (2)  ·  Intestinal Neoplasms (2)  ·  Kidney Diseases (2)  ·  Kidney Neoplasms (2)  ·  Lung Diseases (2)

Interventions

entrectinib (1)

Sponsors

Hoffmann-La Roche (1)  ·  University Hospital, Antwerp (1)

Countries

Belgium (2)  ·  Australia (1)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Results publications

PMID 29118225, PMID 31838007, PMID 31838015, PMID 33646820, PMID 34427452, PMID 34924145, PMID 36924196, PMID 38848521, PMID 39549678, PMID 40086048, PMID 40341199

NIH funding

2015 (1), 2023 (1)